• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新加坡一家大型教学医院艰难梭菌感染的流行病学

Epidemiology of Clostridium difficile infection in a large teaching hospital in Singapore.

作者信息

Koh Tse Hsien, Tan Ai Ling, Tan Mee Lee, Wang Grace, Song Keang Peng

机构信息

Department of Pathology, Singapore General Hospital, University of Singapore, Singapore.

出版信息

Pathology. 2007 Aug;39(4):438-42. doi: 10.1080/00313020701444507.

DOI:10.1080/00313020701444507
PMID:17676487
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7130798/
Abstract

AIMS

We undertook this study to define the incidence of toxigenic Clostridium difficile in our hospital and to characterise the isolates.

METHODS

All unformed stool was tested for the presence of Toxin A (TcdA) and Toxin B (TcdB), and cultured for C. difficile. Culture filtrates were also tested for TcdA and TcdB. Detection of tcdA and tcdB genes was carried out for A(-)B(+) strains by polymerase chain reaction (PCR).The minimum inhibitory concentrations (MICs) of metronidazole, vancomycin and clindamycin for all isolates were tested using the Etest. PCR ribotyping was carried out on all isolates.

RESULTS

The incidence of Clostridium difficile associated disease (CDAD) was 3.2 cases per 1000 admissions or discharges and 53.8 cases per 100 000 patient days. Most cases occurred in renal and haematology patients. CDAD was more common in patients aged over 50 years and of male gender. The Indian population was under-represented. Fourteen (11.8%) isolates were A(-)B(+). All strains were susceptible to metronidazole but one strain showed intermediate resistance to vancomycin. Only 12.8% of the isolates were susceptible to clindamycin. Thirty-five isolates had PCR ribotype A, of which 29 (83%) had a clindamycin MIC >256 mg/L. Thirty-three had PCR ribotype B, of which only one (3%) had a clindamycin MIC >256 mg/L. The 14 A(-)B(+) strains were all PCR ribotype C, and had a range of MICs for clindamycin from 2 to >256 mg/L.

CONCLUSIONS

The incidence of CDAD in our hospital is relatively low. Isolates remain susceptible to metronidazole and vancomycin.

摘要

目的

我们开展本研究以确定我院产毒艰难梭菌的发病率并对分离株进行特征分析。

方法

对所有不成形粪便检测毒素A(TcdA)和毒素B(TcdB)的存在情况,并进行艰难梭菌培养。培养滤液也检测TcdA和TcdB。通过聚合酶链反应(PCR)对A(-)B(+)菌株进行tcdA和tcdB基因检测。使用Etest检测所有分离株对甲硝唑、万古霉素和克林霉素的最低抑菌浓度(MIC)。对所有分离株进行PCR核糖体分型。

结果

艰难梭菌相关疾病(CDAD)的发病率为每1000例入院或出院患者中有3.2例,每100000患者日中有53.8例。大多数病例发生在肾脏和血液科患者中。CDAD在50岁以上男性患者中更为常见。印度人群代表性不足。14株(11.8%)分离株为A(-)B(+)。所有菌株对甲硝唑敏感,但有1株对万古霉素呈中度耐药。仅12.8%的分离株对克林霉素敏感。35株分离株具有PCR核糖体分型A,其中29株(83%)的克林霉素MIC>256 mg/L。33株具有PCR核糖体分型B,其中只有1株(3%)的克林霉素MIC>256 mg/L。14株A(-)B(+)菌株均为PCR核糖体分型C,克林霉素MIC范围为2至>256 mg/L。

结论

我院CDAD的发病率相对较低。分离株对甲硝唑和万古霉素仍敏感。

相似文献

1
Epidemiology of Clostridium difficile infection in a large teaching hospital in Singapore.新加坡一家大型教学医院艰难梭菌感染的流行病学
Pathology. 2007 Aug;39(4):438-42. doi: 10.1080/00313020701444507.
2
A multicenter-based study on epidemiology, antibiotic susceptibility and risk factors of toxigenic Clostridium difficile in hospitalized patients in southwestern Iran.伊朗西南部住院患者中产毒艰难梭菌的流行病学、抗生素敏感性及危险因素的多中心研究
Infez Med. 2018 Dec 1;26(4):308-315.
3
[Epidemiological study of Clostridium difficile strains isolated in Jean-Verdier-René-Muret hospitals from 2001 to 2007].[2001年至2007年在让-韦迪耶-勒内-米雷医院分离出的艰难梭菌菌株的流行病学研究]
Pathol Biol (Paris). 2008 Nov-Dec;56(7-8):412-6. doi: 10.1016/j.patbio.2008.07.009. Epub 2008 Oct 7.
4
First report of Clostridium difficile NAP1/027 in a Mexican hospital.墨西哥一家医院艰难梭菌NAP1/027的首次报告。
PLoS One. 2015 Apr 27;10(4):e0122627. doi: 10.1371/journal.pone.0122627. eCollection 2015.
5
Antimicrobial activity of LFF571 and three treatment agents against Clostridium difficile isolates collected for a pan-European survey in 2008: clinical and therapeutic implications.LFF571 与三种治疗药物对 2008 年全欧调查中收集的艰难梭菌分离株的抗菌活性:临床和治疗意义。
J Antimicrob Chemother. 2013 Jun;68(6):1305-11. doi: 10.1093/jac/dkt013. Epub 2013 Feb 18.
6
Molecular Characterization of Clostridium difficile Isolates from Human Subjects and the Environment.来自人类受试者和环境的艰难梭菌分离株的分子特征分析
PLoS One. 2016 Mar 24;11(3):e0151964. doi: 10.1371/journal.pone.0151964. eCollection 2016.
7
Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates.欧洲艰难梭菌感染的前瞻性研究及分离株的表型和基因型特征分析
Clin Microbiol Infect. 2007 Nov;13(11):1048-57. doi: 10.1111/j.1469-0691.2007.01824.x. Epub 2007 Sep 11.
8
Comparison of Clostridium difficile isolates from individuals with recurrent and single episode of infection.感染复发个体与单次感染个体的艰难梭菌分离株比较。
Anaerobe. 2015 Jun;33:105-8. doi: 10.1016/j.anaerobe.2015.03.003. Epub 2015 Mar 11.
9
Prevalence and association of PCR ribotypes of Clostridium difficile isolated from symptomatic patients from Warsaw with macrolide-lincosamide-streptogramin B (MLSB) type resistance.从华沙有症状患者中分离出的艰难梭菌PCR核糖体分型的流行情况及其与大环内酯-林可酰胺-链阳菌素B(MLSB)型耐药性的关联
J Med Microbiol. 2006 Feb;55(Pt 2):207-213. doi: 10.1099/jmm.0.46213-0.
10
Two Clusters of Fluoroquinolone and Clindamycin-Resistant Clostridium difficile PCR Ribotype 001 Strain Recognized by Capillary Electrophoresis Ribotyping and Multilocus Variable Tandem Repeat Analysis.通过毛细管电泳核糖分型和多位点可变串联重复序列分析识别出的两簇耐氟喹诺酮和克林霉素的艰难梭菌PCR核糖型001菌株
Microb Drug Resist. 2017 Jul;23(5):609-615. doi: 10.1089/mdr.2016.0159. Epub 2016 Nov 18.

引用本文的文献

1
Multi-epitope vaccine design against using the ABC-type transport system protein.针对使用ABC型转运系统蛋白的多表位疫苗设计。
Bioinformation. 2025 May 31;21(5):990-996. doi: 10.6026/973206300210990. eCollection 2025.
2
Epidemiology of Clostridium (Clostridioides) difficile Infection in Southeast Asia.东南亚艰难梭菌感染的流行病学
Am J Trop Med Hyg. 2022 Aug 8;107(3):517-26. doi: 10.4269/ajtmh.21-1167.
3
Risk factors and treatment outcomes of severe Clostridioides difficile infection in Singapore.新加坡艰难梭菌感染严重患者的风险因素和治疗结果。
Sci Rep. 2019 Sep 17;9(1):13440. doi: 10.1038/s41598-019-49794-7.
4
Clostridium difficile-associated Diarrhea in Developing Countries: A Systematic Review and Meta-Analysis.发展中国家艰难梭菌相关性腹泻:一项系统评价与荟萃分析
Infect Dis Ther. 2019 Mar;8(1):87-103. doi: 10.1007/s40121-019-0231-8. Epub 2019 Jan 18.
5
Global burden of infections: a systematic review and meta-analysis.全球 感染负担:系统评价和荟萃分析。
J Glob Health. 2019 Jun;9(1):010407. doi: 10.7189/jogh.09.010407.
6
The emergence of Clostridium difficile infection in Asia: A systematic review and meta-analysis of incidence and impact.亚洲艰难梭菌感染的出现:发病率及影响的系统评价与荟萃分析
PLoS One. 2017 May 2;12(5):e0176797. doi: 10.1371/journal.pone.0176797. eCollection 2017.
7
Clostridium difficile Infection.艰难梭菌感染。
Microbiol Spectr. 2016 Jun;4(3). doi: 10.1128/microbiolspec.EI10-0007-2015.
8
Molecular epidemiology of Clostridium difficile at a medical center in Taiwan: persistence of genetically clustering of A⁻B⁺ isolates and increase of A⁺B⁺ isolates.台湾某医学中心艰难梭菌的分子流行病学:A⁻B⁺分离株遗传聚类的持续存在和 A⁺B⁺分离株的增加。
PLoS One. 2013 Oct 7;8(10):e75471. doi: 10.1371/journal.pone.0075471. eCollection 2013.
9
Epidemiology of Clostridium difficile infection in Asia.亚洲艰难梭菌感染的流行病学。
Antimicrob Resist Infect Control. 2013 Jul 1;2(1):21. doi: 10.1186/2047-2994-2-21.
10
Clostridium difficile-associated diarrhea in radiooncology: an underestimated problem for the feasibility of the radiooncological treatment?放化疗相关性艰难梭菌相关性腹泻:对放化疗可行性的一个被低估的问题?
Radiat Oncol. 2011 Aug 1;6:89. doi: 10.1186/1748-717X-6-89.

本文引用的文献

1
Epidemiology and control of SARS in Singapore.新加坡严重急性呼吸综合征的流行病学与防控
Ann Acad Med Singap. 2006 May;35(5):301-16.
2
Antimicrobial susceptibility pattern of Clostridium difficile and its relation to PCR ribotypes in a Swedish university hospital.瑞典一家大学医院中艰难梭菌的抗菌药物敏感性模式及其与PCR核糖型的关系。
Antimicrob Agents Chemother. 2006 May;50(5):1890-2. doi: 10.1128/AAC.50.5.1890-1892.2006.
3
A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality.艰难梭菌相关性腹泻的多机构主要克隆性暴发,发病率和死亡率高。
N Engl J Med. 2005 Dec 8;353(23):2442-9. doi: 10.1056/NEJMoa051639. Epub 2005 Dec 1.
4
Clostridium difficile: responding to a new threat from an old enemy.艰难梭菌:应对宿敌带来的新威胁
Infect Control Hosp Epidemiol. 2005 Aug;26(8):672-5. doi: 10.1086/502600.
5
Laboratory diagnosis of Clostridium difficile-associated diarrhoea: a plea for culture.艰难梭菌相关性腹泻的实验室诊断:呼吁进行培养
J Med Microbiol. 2005 Feb;54(Pt 2):187-191. doi: 10.1099/jmm.0.45844-0.
6
Molecular epidemiology of hospital-associated and community-acquired Clostridium difficile infection in a Swedish county.瑞典某郡医院获得性和社区获得性艰难梭菌感染的分子流行病学
J Clin Microbiol. 2004 Aug;42(8):3635-43. doi: 10.1128/JCM.42.8.3635-3643.2004.
7
Characterization of toxin A-negative, toxin B-positive Clostridium difficile isolates from outbreaks in different countries by amplified fragment length polymorphism and PCR ribotyping.通过扩增片段长度多态性和PCR核糖体分型对来自不同国家暴发疫情的产毒素A阴性、产毒素B阳性艰难梭菌分离株进行特征分析。
J Clin Microbiol. 2004 Mar;42(3):1035-41. doi: 10.1128/JCM.42.3.1035-1041.2004.
8
Epidemiology and molecular characterization of Clostridium difficile strains from patients with diarrhea: low disease incidence and evidence of limited cross-infection in a Swedish teaching hospital.腹泻患者艰难梭菌菌株的流行病学及分子特征:瑞典一家教学医院疾病发病率低且交叉感染有限的证据
J Clin Microbiol. 2003 Sep;41(9):4031-7. doi: 10.1128/JCM.41.9.4031-4037.2003.
9
International typing study of toxin A-negative, toxin B-positive Clostridium difficile variants.毒素A阴性、毒素B阳性艰难梭菌变体的国际分型研究
J Clin Microbiol. 2003 Apr;41(4):1543-7. doi: 10.1128/JCM.41.4.1543-1547.2003.
10
Prevalence and genetic characterization of toxin A variant strains of Clostridium difficile among adults and children with diarrhea in France.法国腹泻成人和儿童中艰难梭菌毒素A变异菌株的流行情况及基因特征
J Clin Microbiol. 2002 Jun;40(6):2079-83. doi: 10.1128/JCM.40.6.2079-2083.2002.